Assisted injection in outdoor venues: An observational study of risks and implications for service delivery and harm reduction programming

Harm Reduction Journal

Volumn 7, Issue , 2010, Pages

  Lloyd Smith, Elisa ^a   Rachlis, Beth S ^a   Tobin, Diane ^b   Stone, Dave ^b   Li, Kathy ^a   Small, Will ^a   Wood, Evan ^a   Kerr, Thomas ^a  

^a ST PAUL S HOSPITAL   (Canada)

^b VANCOUVER AREA NETWORK OF DRUG USERS   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DIAMORPHINE;

ABORIGINE; ADULT; ARTICLE; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; COHORT ANALYSIS; FEMALE; HARM REDUCTION; HEALTH CARE DELIVERY; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MALE; OBSERVATIONAL STUDY; PROSTITUTION; SEX RATIO;

EID: 79955615358     PISSN: None     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/1477-7517-7-6     Document Type: Article

References (30)

1. UNAIDS High Coverage Sites HIV Prevention among Injecting Drug Users in Transitional and Developing Countries: Case Studies. Geneva 2008, UNAIDS.
2. Wood E, Kerr T, Lloyd-Smith E, Buchner C, Marsh D, Montaner J, et al. Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduct J 2004, 1:9. 10.1186/1477-7517-1-9, 535533, 15535885.
3. Buxton J. Vancouver drug use epidemiology: Vancouver site report for the Canadian Community Epidemiology Network on Drug Use (CCENDU). The Netowrk 2005, http://vancouver.ca/fourpillars/pdf/report_vancouver_2005.pdf
4. Wood E, Tyndall M, Li K, Lloyd-Smith E, Small W, Montaner J, et al. Do Supervised Injecting Facilities Attract Higher-Risk Injection Drug Users?. Am J Prev Med 2005, 29:126-130. 10.1016/j.amepre.2005.04.011, 16005809.
5. Kerr T, Tyndall M, Li K, Montaner J, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet 2005, 366:316-318. 10.1016/S0140-6736(05)66475-6, 16039335.
6. Kerr T, Wood E, Small D, Palepu A, Tyndall MW. Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside. CMAJ 2003, 169:759-763. 203277, 14557313.
7. Health Canada Application for an exemption under Section 56 of the Controlled Drugs and Substances Act for a scientific purpose for a pilot supervised injection site. 2002, Office of Drug Strategy and Controlled Substances Programme, Health Canada.
8. Pearshouse R, Elliott R. A Helping Hand: Legal Issues Related to Assisted Injection at Supervised Injection Facilities. 2007, Toronto: Canadian HIV/AIDS Legal Network.
9. Small W, Rhodes T, Wood E, Kerr T. Public injection settings in Vancouver: Physical environment, social context and risk. International J Drug Policy 2007, 18:27-36.
10. Wood E, Spittal PM, Kerr T, Small W, Tyndall MW, O'Shaughnessy MV, et al. Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: Implications for HIV prevention. Can J Public Health 2003, 94:355-359.
11. Kral AH, Bluthenthal RN, Erringer EA, Lorvick J, Edlin BR. Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction 1999, 94:675-683. 10.1046/j.1360-0443.1999.9456755.x, 10563032.
12. Kerr T, Fairbairn N, Tyndall M, Marsh D, Li K, Montaner J, et al. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend 2007, 87:39-45. 10.1016/j.drugalcdep.2006.07.009, 16959438.
13. O'Connell JM, Kerr T, Li K, Tyndall MW, Hogg RS, Montaner JS, et al. Requiring help injecting independently predicts incident HIV infection among injection drug users. J Acquir Immune Defic Syndr 2005, 40:83-88. 10.1097/01.qai.0000157006.28535.mL, 16123687.
14. Wood E, Tyndall MW, Spittal PM, Li K, Kerr T, Hogg RS, et al. Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?. CMAJ 2001, 165:405-410. 81364, 11531048.
15. Tyndall MW, Currie S, Spittal P, Li K, Wood E, O'Shaughnessy MV, et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 2003, 17:887-893. 10.1097/00002030-200304110-00014, 12660536.
16. Diggle PJ, Liang K, Zeger S. Analysis of Longitudinal Data. 1996, New York: Oxford University Press.
17. Bourgois P, Prince B, Moss A. The everyday violence of Hepatitis C among young women who inject drugs in San Francisco. Human Organization 2004, 63:253-264. 1458969, 16685288.
18. Fairbairn N, Small W, Van B, Wood E, Kerr T. Social and structural factors that shape assisted injecting practices among injection drug users in Vancouver, Canada: A qualitative study. Harm Reduct J
19. Miller CL, Kerr T, Frankish JC, Spittal PM, Li K, Schechter MT, et al. Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies. Subst Use Misuse 2006, 41:199-210. 10.1080/10826080500391795, 16393742.
20. Lloyd-Smith E, Kerr T, Hogg RS, Li K, Montaner JS, Wood E. Prevalence and correlates of abscesses among a cohort of injection drug users. Harm Reduct J 2005, 2:24. 10.1186/1477-7517-2-24, 1308840, 16281979.
21. Lloyd-Smith E, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T. Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study. BMC Public Health 2008, 8:405. 10.1186/1471-2458-8-405, 2621202, 19068133.
22. Lloyd-Smith E, Wood E, Li K, Montaner JSG, Kerr T. Incidence and determinants of initiation into cocaine injection and correlates of frequent cocaine injectors. Drug Alcohol Depend 2008, 99:176-182. 10.1016/j.drugalcdep.2008.07.003, 2649881, 18805655.
23. Shannon K, Kerr T, Allinott S, Chettiar J, Shoveller J, Tyndall MW. Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work. Soc Sci Med 2007, 66:911-921. 10.1016/j.socscimed.2007.11.008, 18155336.
24. Shannon K, Rusch M, Shoveller J, Alexson D, Gibson K, Tyndall MW. Mapping violence and policing as an environmental-structural barrier to health service and syringe availability among substance-using women in street-level sex work. International J Drug Policy 2008, 19:140-147.
25. Small W, Wood E, Lloyd-Smith E, Tyndall M, Kerr T. Accessing care for injection-related injections through a medically supervised injecting facility: a qualitative study. Drug Alcohol Depend 2008, 98:159-162. 10.1016/j.drugalcdep.2008.05.014, 18650034.
26. Lloyd-Smith E, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T. Determinants of cutaneous injection-related infection care at a supervised injection facility. Ann Epidemiol 2009, 19:404-409. 10.1016/j.annepidem.2009.03.007, 19364660.
27. Kerr T, Small W, Peeace W, Douglas D, Pierre A, Wood W. Harm reducation by a 'user-run' organization: a case study of the Vancouver Area Network of Drug Users (VANDU). International J Drug Policy 2006, 17:61-69.
28. Tyndall MW, Craib KJ, Currie S, Li K, O'Shaughnessy MV, Schechter MT. Impact of HIV infection on mortality in a cohort of injection drug users. J Acquir Immune Defic Syndr 2001, 28:351-357.
29. Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend 1998, 51:253-263. 10.1016/S0376-8716(98)00028-3, 9787998.
30. Lovell AM. Risking risk: the influence of types of capital and social networks on the injection practices of drug users. Soc Sci Med 2002, 55:803-821. 10.1016/S0277-9536(01)00204-0, 12190272.